Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

6.4K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

7.7K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.7K
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)01:15

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

908
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...
908
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)01:20

¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)

1.5K
When proton-coupled carbon-13 spectra are simplified by a broadband proton decoupling technique, structural information about the coupled protons is lost. Distortionless enhancement by polarization transfer (DEPT) is a technique that provides information on the number of hydrogens attached to each carbon in a molecule. While the DEPT experiment utilizes complex pulse sequences, the pulse delay and flip angle are specifically manipulated. The resulting signals have different phases depending on...
1.5K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.5K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Postpartum Mental Health and Healthy Lifestyle Behaviors in Women of Color Who Are Pregnant and Experiencing Depression, Anxiety, and Stress Through Group Prenatal Care: A Randomized Controlled Trial.

Journal of midwifery & women's health·2026
Same author

A functional map of phosphoprotein phosphatase regulation identifies an evolutionarily conserved reductase for the catalytic metal ions.

Nature communications·2026
Same author

Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs.

Acta chirurgica Belgica·2026
Same author

Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.

Blood advances·2026
Same author

Multivalent nanobodies for potent and broad neutralization of Staphylococcus aureus toxins.

Nature communications·2026
Same author

Hydrocephalus caused by <i>Katnip</i> deletion is linked to increased ciliogenesis and reduced proliferation of neuroprogenitor cells.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Dec 23, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.3K

Selective PP2A Enhancement through Biased Heterotrimer Stabilization.

Daniel Leonard1, Wei Huang2, Sudeh Izadmehr3

  • 1Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Cell
|April 22, 2020
PubMed
Summary

A novel molecule, DT-061, stabilizes the B56α-PP2A enzyme, enhancing its activity against cancer targets like c-Myc. This discovery offers new therapeutic strategies for diseases involving protein phosphatase 2A (PP2A) dysfunction.

Keywords:
B56αPP2ASMAPc-Myccancercryo-EMphosphatasesmall molecule

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.5K
Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli
07:35

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli

Published on: August 3, 2017

6.9K

Related Experiment Videos

Last Updated: Dec 23, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.3K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.5K
Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli
07:35

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli

Published on: August 3, 2017

6.9K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Protein phosphatase 2A (PP2A) dysfunction is implicated in various diseases, including cancer.
  • PP2A's activity is modulated by over 40 regulatory B subunits, influencing its substrate specificity and assembly into heterogeneous heterotrimers.
  • Understanding PP2A complex assembly and regulation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the mechanism of action of the small molecule DT-061.
  • To elucidate how DT-061 stabilizes the B56α-PP2A holoenzyme.
  • To provide insights into PP2A complex assembly and identify therapeutic targets.

Main Methods:

  • 3.6 Å structural analysis of the DT-061 bound B56α-PP2A holoenzyme.
  • Investigation of molecular interactions between DT-061 and PP2A subunits.
  • Assessment of DT-061's effect on PP2A activity and substrate dephosphorylation.

Main Results:

  • DT-061 specifically stabilizes the B56α-PP2A holoenzyme in an active conformation.
  • The molecule engages all three PP2A subunits, preventing holoenzyme dissociation.
  • DT-061 facilitates the dephosphorylation of specific substrates, including the oncogenic protein c-Myc.

Conclusions:

  • DT-061 employs a unique interfacial stabilization mechanism for therapeutic targeting.
  • The findings offer fundamental insights into PP2A complex assembly and regulation.
  • This study aids in developing novel phosphatase-based therapeutics for diseases driven by aberrant protein phosphorylation.